![Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells](https://www.spandidos-publications.com/article_images/ijo/41/3/IJO-41-03-1148-g00.jpg)
Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells
![5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221000706-gr1.jpg)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect
![Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines](https://www.spandidos-publications.com/article_images/or/45/4/or-45-04-7978-g00.jpg)
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
![Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments | Actas Dermo-Sifiliográficas Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1578219016302207:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Auh3kCYDQbyHLI5O9kk64mBLwju6FizE7LcSUhbdQrZ7AeTU9nO+2W19YBxLreYlpD8gjPSehfwOuzWoJKa9XdpgsAx9zwAqaH8DC21Tz2iz1P6q5mnWa2tswtALzUbH1uAlrAl0KGCHDyKlvT4Pn2b+VJ3ZXiMjFkxMSq+tjV/KqPAhl+iBDqwuD32VUq7OVaQ2xtT5wFQMDpR8woQT5I0=)
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments | Actas Dermo-Sifiliográficas
![PharmaConnect on Twitter: "Leucovorin (reduced form of folic acid ) stabilize the binding of dUMP — Thyminidylate synthetase. So, will ⬆️ the activity of 5-FU. 5-Fluorouracil Mechanism of action 💉: https://t.co/f35rSg13Ye" / Twitter PharmaConnect on Twitter: "Leucovorin (reduced form of folic acid ) stabilize the binding of dUMP — Thyminidylate synthetase. So, will ⬆️ the activity of 5-FU. 5-Fluorouracil Mechanism of action 💉: https://t.co/f35rSg13Ye" / Twitter](https://pbs.twimg.com/media/DxD_gF-UcAI3gbj.jpg)
PharmaConnect on Twitter: "Leucovorin (reduced form of folic acid ) stabilize the binding of dUMP — Thyminidylate synthetase. So, will ⬆️ the activity of 5-FU. 5-Fluorouracil Mechanism of action 💉: https://t.co/f35rSg13Ye" / Twitter
![5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes - Blondy - 2020 - Cancer Science - Wiley Online Library 5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes - Blondy - 2020 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3fdf95a7-4fd1-4574-b5f4-f80064a7a686/cas14532-fig-0002-m.jpg)
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes - Blondy - 2020 - Cancer Science - Wiley Online Library
![Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability | Drug Metabolism & Disposition Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/48/12/1257/F1.large.jpg)
Pharmacokinetic and Pharmacodynamic Factors Contribute to Synergism between Let-7c-5p and 5-Fluorouracil in Inhibiting Hepatocellular Carcinoma Cell Viability | Drug Metabolism & Disposition
![Biology | Free Full-Text | Recent Updates on Mechanisms of Resistance to 5- Fluorouracil and Reversal Strategies in Colon Cancer Treatment Biology | Free Full-Text | Recent Updates on Mechanisms of Resistance to 5- Fluorouracil and Reversal Strategies in Colon Cancer Treatment](https://www.mdpi.com/biology/biology-10-00854/article_deploy/html/images/biology-10-00854-g001.png)
Biology | Free Full-Text | Recent Updates on Mechanisms of Resistance to 5- Fluorouracil and Reversal Strategies in Colon Cancer Treatment
![Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids](https://f6publishing.blob.core.windows.net/967deb4b-7171-47df-b35e-2d626a02c328/WJGO-12-942-g001.png)
Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
![Frontiers | 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent | Oncology Frontiers | 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent | Oncology](https://www.frontiersin.org/files/Articles/658636/fonc-11-658636-HTML-r1/image_m/fonc-11-658636-g001.jpg)
Frontiers | 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent | Oncology
![5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study - Journal of Oral and Maxillofacial Surgery 5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study - Journal of Oral and Maxillofacial Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/20d1c786-9cec-44e0-a804-a2ae46e6f88e/gr1_lrg.jpg)